BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 25305313)

  • 1. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
    Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
    PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.
    Zhou W; Zhou X; Gaowa S; Meng Q; Zhan Z; Liu J; Li J; Fan H; Liu Z
    Transplantation; 2015 Jul; 99(7):1356-64. PubMed ID: 25856405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.
    Gajardo T; Morales RA; Campos-Mora M; Campos-Acuña J; Pino-Lagos K
    Immunology; 2015 Sep; 146(1):81-8. PubMed ID: 25988395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
    Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
    Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrable mouse forkhead box protein 3 alleviates experimental arthritis in mice by up-regulating regulatory T cells.
    Liu X; Ji B; Sun M; Wu W; Huang L; Sun A; Zong Y; Xia S; Shi L; Qian H; Xu W; Shao Q
    Clin Exp Immunol; 2015 Jul; 181(1):87-99. PubMed ID: 25809415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.
    Lee K; Hwang S; Paik DJ; Kim WK; Kim JM; Youn J
    Clin Exp Immunol; 2012 Oct; 170(1):66-76. PubMed ID: 22943202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive IL-17A
    Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
    Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.
    Eggenhofer E; Renner P; Soeder Y; Popp FC; Hoogduijn MJ; Geissler EK; Schlitt HJ; Dahlke MH
    Transpl Immunol; 2011 Sep; 25(2-3):141-7. PubMed ID: 21704160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
    Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
    Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Endogenous Melatonin in the Regulation of Th17/Treg Balance during Pregnancy.
    Glebezdina NS; Olina AA; Nekrasova IV; Kuklina EM
    Bull Exp Biol Med; 2018 Mar; 164(4):462-465. PubMed ID: 29504099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.
    Guo H; Zhao N; Gao H; He X
    Scand J Immunol; 2017 Nov; 86(5):389-395. PubMed ID: 28888053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.
    Wu J; Zhou C; Chen W; Xie A; Li J; Wang S; Ye P; Wang W; Xia J
    Transplantation; 2013 Feb; 95(3):434-41. PubMed ID: 23296151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fyn promotes Th17 differentiation by regulating the kinetics of RORγt and Foxp3 expression.
    Ueda A; Zhou L; Stein PL
    J Immunol; 2012 Jun; 188(11):5247-56. PubMed ID: 22539787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enforced ROR(gamma)t expression in haematopoietic stem cells increases regulatory T cell number, which reduces immunoreactivity and attenuates hypersensitivity in vivo.
    Fujisawa Y; Nabekura T; Kawachi Y; Otsuka F; Onodera M
    Asian Pac J Allergy Immunol; 2011 Mar; 29(1):86-93. PubMed ID: 21560493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.